Insider Selling: Paragon 28, Inc. (NYSE:FNA) Major Shareholder Sells 619,747 Shares of Stock

Paragon 28, Inc. (NYSE:FNA) major shareholder Mvm Partners, Llc sold 619,747 shares of Paragon 28 stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $12.99, for a total value of $8,050,513.53. Following the completion of the sale, the insider now directly owns 9,609,771 shares in the company, valued at $124,830,925.29. This represents a 6.06 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Mvm Partners, Llc also recently made the following trade(s):

• On Thursday, March 6th, Mvm Partners, Llc sold 164,664 shares of Paragon 28 stock. The shares were sold at an average price of $13.01, for a total value of $2,142,278.64.
• On Monday, January 27th, Mvm Partners, Llc sold 27,142 shares of Paragon 28 stock. The shares were sold at an average price of $11.62, for a total value of $315,390.04.
• On Thursday, January 23rd, Mvm Partners, Llc sold 20,136 shares of Paragon 28 stock. The shares were sold at an average price of $11.63, for a total value of $234,181.68.

Paragon 28 Price Performance

Shares of NYSE FNA opened at $13.03 on Friday. The business’s 50 day moving average price is $12.07 and its two-hundred day moving average price is $9.33. The company has a market cap of $1.09 billion, a PE ratio of -17.60 and a beta of 1.54. The company has a quick ratio of 1.60, a current ratio of 3.50 and a debt-to-equity ratio of 0.79. Paragon 28, Inc. has a twelve month low of $4.65 and a twelve month high of $13.13.

Hedge Funds Weigh In On Paragon 28

A number of institutional investors have recently bought and sold shares of FNA. Barclays PLC boosted its holdings in shares of Paragon 28 by 180.6% during the third quarter. Barclays PLC now owns 84,812 shares of the company’s stock worth $567,000 after acquiring an additional 54,591 shares during the period. JPMorgan Chase & Co. boosted its holdings in shares of Paragon 28 by 2,141.7% during the third quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company’s stock worth $5,243,000 after acquiring an additional 749,865 shares during the period. GSA Capital Partners LLP bought a new stake in shares of Paragon 28 during the third quarter worth approximately $386,000. Ballentine Partners LLC boosted its holdings in shares of Paragon 28 by 15.0% during the fourth quarter. Ballentine Partners LLC now owns 15,630 shares of the company’s stock worth $161,000 after acquiring an additional 2,043 shares during the period. Finally, State Street Corp boosted its holdings in shares of Paragon 28 by 2.6% during the third quarter. State Street Corp now owns 1,563,331 shares of the company’s stock worth $10,443,000 after acquiring an additional 39,075 shares during the period. Institutional investors and hedge funds own 63.57% of the company’s stock.

Analysts Set New Price Targets

FNA has been the topic of a number of recent research reports. Stephens reaffirmed an “equal weight” rating and issued a $13.00 target price (down previously from $14.00) on shares of Paragon 28 in a research report on Thursday, January 30th. Needham & Company LLC reaffirmed a “hold” rating and issued a $13.00 target price on shares of Paragon 28 in a research report on Wednesday, January 29th. Canaccord Genuity Group set a $13.00 target price on Paragon 28 in a research report on Wednesday, January 29th. Finally, William Blair downgraded Paragon 28 from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $14.20.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.